None listed
Conditions
Brief summary
This study is evaluating the feasibility of exercise cardiac positron emission technology (PET) imaging to determine cardiac risk for patients undergoing major cancer surgery. Who is it for? You may be eligible to join this study if you greater than or equal to 18 years of age and are scheduled to attend pre-admission clinic review and cardiopulmonary exercise testing prior to major thoracic or abdominal surgery at Peter MacCallum Cancer Centre. Study details: All participants in this study will undergo cardiopulmonary exercise testing at the preadmission clinic to assess heart and lung function. You will be required to fast for 8 hours prior to arriving at the clinic, and you will be asked to consume a high fat and low carbohydrate meal 12 hours prior to the testing. Radiolabelled glucose will then be intravenously injected, i.e. administered directly into your vein. A positron emission technology (PET) scan of the heart will be performed 1-2 hours after the radiolabelled glucose injection. The diagnostic tests used in this study may have the potential to rapidly provide more specific information regarding myocardial metabolic function than CPET, and also enable anatomic localisation of areas of the myocardium which are susceptible to ischaemia under conditions of metabolic stress. We therefore hope to improve on the current tests available to identify patients at high risks of heart complications after surgery.
Interventions
This is an observational study, investigating the feasibility and utility of preoperative exercise cardiac positron emission technology (PET) imaging in identifying patients with cardiac disease preoperatively. Participants will undergo cardiopulmonary exercise testing (as per standard institutional protocol before major cancer surgery), which involves 10-12 minutes of cycling on a stationary bicycle. Endothelial function will be assessed non-invasively using a finger tonometry device (EndoPAT) before cardiopulmonary exercise testing. This involves application of a finger-probe on each hand which measures arterial pulse wave amplitude using plethysmographic technology. The testing process involves a resting measurement phase, forearm occlusion (using a blood pressure cuff inflated above systolic blood pressure on one arm for 5 minutes), and a final measurement of the magnitude of reactive hyperaemia after release of the forearm blood flow occlusion. Exercise PET imaging involves intravenous injection of radiolabelled glucose after peak exercise through an intravenous cannula. The radiolabelled glucose is taken up by ischaemic myocardium in the fasted state after a high fat and low carbohydrate meal. PET imaging then uses detection of emitted positrons to generate a tomographic image of the heart. Patients must fast for 4-6 hours prior to the cardiopulmonary exercise test, and must consume a high fat, low carbohydrate meal for dinner the evening prior to the test and at 4-6 hours before the exercise test. A range on suggested high fat, low carbohydrate meals options will be provided to participants to choose from. The total duration of cardiopulmonary exercise testing is approximately 60 minutes. Participants will undergo PET scans 1-2 hours after the cardiopulmonary exercise test. The cardiac PET scan duration is approximately 10 minutes.
Sponsors
Eligibility
Inclusion criteria
Greater than or equal to 18 years of age. Informed consent. Patients scheduled to attend pre-admission clinic review and cardiopulmonary exercise testing prior to major surgery at Peter MacCallum Cancer Centre, or patients with an indication for cardiac stress testing Are assessed as either high predicted risk or low predicted risk: High preoperative risk (Lee Revised Cardiac Risk Index greater than or equal to 2), OR Low preoperative risk (No risk factors other than high risk surgery, using the Lee Revised Cardiac Risk Index) Participant assessed as being clinically suitable for CPET testing as per the American Thoracic Society guidelines
Exclusion criteria
Unable to provide informed consent Unable to exercise Intermediate risk (not meeting criteria for high or low risk groups). Pregnancy or breastfeeding. Insulin dependent diabetes mellitus.